Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0YQ3M
|
|||
| Former ID |
DIB013113
|
|||
| Drug Name |
EP-2104R
|
|||
| Synonyms |
Gadolinium labeled fibrin-binding peptide, EPIX Medical
Click to Show/Hide
|
|||
| Indication | Cardiovascular disease [ICD-11: BA00-BE2Z; ICD-10: I00-I99] | Discontinued in Phase 2 | [1] | |
| Company |
Epix Pharmaceutical
|
|||
| Structure |
 |
Download2D MOL
|
||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Fibrin (FG) | Target Info | Modulator | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800018915) | |||
| REF 2 | EP-2104R: a fibrin-specific gadolinium-Based MRI contrast agent for detection of thrombus. J Am Chem Soc. 2008 May 7;130(18):6025-39. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.